
Leading Oncology Country Markets Databank
Description
Leading Oncology Country Markets Databank
The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $94,840.8 Million in 2020, and is anticipated to reach $162,447.5 Million by 2029, registering a CAGR of 6.20%. Asia-Pacific and Europe collectively expected to account for about 64.7% share of the Oncology market in 2020, with the former constituting around 34.4% share. Asia-Pacific and Europe are expected to witness significant growth rates at a CAGR of 6.20% and 3.32% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 64.7% in the overall Oncology market in 2020, and is anticipated to reach 68.5% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
The Oncology market was valued at $275,700.0 Million in 2020, and is projected to reach $400,345.5 Million by 2029 growing at a CAGR of 4.28% from 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $94,840.8 Million in 2020, and is anticipated to reach $162,447.5 Million by 2029, registering a CAGR of 6.20%. Asia-Pacific and Europe collectively expected to account for about 64.7% share of the Oncology market in 2020, with the former constituting around 34.4% share. Asia-Pacific and Europe are expected to witness significant growth rates at a CAGR of 6.20% and 3.32% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 64.7% in the overall Oncology market in 2020, and is anticipated to reach 68.5% by 2029.
The report provides market intelligence on various market segments and geography, including market size and forecast information. Its primary goals are to deliver a thorough global market intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the market in each region. In addition, we carried out extensive primary research by conducting interviews with key executives in the industry. These interviews helped us to fill any data gaps identified during the secondary research. We used various secondary sources such as encyclopedias, directories, and databases to gather relevant information for this extensive techno-commercial study. We interviewed selected experts from manufacturers and suppliers to obtain and verify critical information, as well as to assess future prospects. The research team evaluated the reliability of the obtained information before using it. In some cases, a combination of multiple sources was used. Sprout Intelligence conducted an in-depth analysis of the market segmentation, which is a crucial component of our market intelligence reports.
Table of Contents
80 Pages
- 1. GLOBAL ONCOLOGY MARKET, BY REGION
- 1.1. OVERVIEW
- 1.2. NORTH AMERICA
- 1.2.1 NORTH AMERICA ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
- 1.2.2 NORTH AMERICA ONCOLOGY MARKET, BY CANCER TYPE
- 1.2.3 NORTH AMERICA ONCOLOGY MARKET, BY COUNTRY
- 1.2.3.1 U.S.
- 1.2.3.1.1 U.S. Oncology Market, By By Cancer Diagnostics & Treatment
- 1.2.3.1.2 U.S. Oncology Market, By Cancer Type
- 1.2.3.2 Canada
- 1.2.3.2.1 Canada Oncology Market, By By Cancer Diagnostics & Treatment
- 1.2.3.2.2 Canada Oncology Market, By Cancer Type
- 1.2.3.3 Mexico
- 1.2.3.3.1 Mexico Oncology Market, By By Cancer Diagnostics & Treatment
- 1.2.3.3.2 Mexico Oncology Market, By Cancer Type
- 1.3. EUROPE
- 1.3.1 EUROPE ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
- 1.3.2 EUROPE ONCOLOGY MARKET, BY CANCER TYPE
- 1.3.3 EUROPE ONCOLOGY MARKET, BY COUNTRY
- 1.3.3.1 Germany
- 1.3.3.1.1 Germany Oncology Market, By By Cancer Diagnostics & Treatment
- 1.3.3.1.2 Germany Oncology Market, By Cancer Type
- 1.3.3.2 France
- 1.3.3.2.1 France Oncology Market, By By Cancer Diagnostics & Treatment
- 1.3.3.2.2 France Oncology Market, By Cancer Type
- 1.3.3.3 UK
- 1.3.3.3.1 UK Oncology Market, By By Cancer Diagnostics & Treatment
- 1.3.3.3.2 UK Oncology Market, By Cancer Type
- 1.3.3.4 Italy
- 1.3.3.4.1 Italy Oncology Market, By By Cancer Diagnostics & Treatment
- 1.3.3.4.2 Italy Oncology Market, By Cancer Type
- 1.3.3.5 Spain
- 1.3.3.5.1 Spain Oncology Market, By By Cancer Diagnostics & Treatment
- 1.3.3.5.2 Spain Oncology Market, By Cancer Type
- 1.3.3.6 Rest of Europe
- 1.3.3.6.1 Rest of Europe Oncology Market, By By Cancer Diagnostics & Treatment
- 1.3.3.6.2 Rest of Europe Oncology Market, By Cancer Type
- 1.4. ASIA-PACIFIC
- 1.4.1 ASIA-PACIFIC ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
- 1.4.2 ASIA-PACIFIC ONCOLOGY MARKET, BY CANCER TYPE
- 1.4.3 ASIA-PACIFIC ONCOLOGY MARKET, BY COUNTRY
- 1.4.3.1 China
- 1.4.3.1.1 China Oncology Market, By By Cancer Diagnostics & Treatment
- 1.4.3.1.2 China Oncology Market, By Cancer Type
- 1.4.3.2 India
- 1.4.3.2.1 India Oncology Market, By By Cancer Diagnostics & Treatment
- 1.4.3.2.2 India Oncology Market, By Cancer Type
- 1.4.3.3 Japan
- 1.4.3.3.1 Japan Oncology Market, By By Cancer Diagnostics & Treatment
- 1.4.3.3.2 Japan Oncology Market, By Cancer Type
- 1.4.3.4 Australia
- 1.4.3.4.1 Australia Oncology Market, By By Cancer Diagnostics & Treatment
- 1.4.3.4.2 Australia Oncology Market, By Cancer Type
- 1.4.3.5 South Korea
- 1.4.3.5.1 South Korea Oncology Market, By By Cancer Diagnostics & Treatment
- 1.4.3.5.2 South Korea Oncology Market, By Cancer Type
- 1.4.3.6 Rest of Asia
- 1.4.3.6.1 Rest of Asia Oncology Market, By By Cancer Diagnostics & Treatment
- 1.4.3.6.2 Rest of Asia Oncology Market, By Cancer Type
- 1.5. REST OF WORLD
- 1.5.1 REST OF WORLD ONCOLOGY MARKET, BY BY CANCER DIAGNOSTICS & TREATMENT
- 1.5.2 REST OF WORLD ONCOLOGY MARKET, BY CANCER TYPE
- 1.5.3 REST OF WORLD ONCOLOGY MARKET, BY COUNTRY
- 1.5.3.1 Brazil
- 1.5.3.1.1 Brazil Oncology Market, By By Cancer Diagnostics & Treatment
- 1.5.3.1.2 Brazil Oncology Market, By Cancer Type
- 1.5.3.2 South Africa
- 1.5.3.2.1 South Africa Oncology Market, By By Cancer Diagnostics & Treatment
- 1.5.3.2.2 South Africa Oncology Market, By Cancer Type
- 1.5.3.3 GCC
- 1.5.3.3.1 GCC Oncology Market, By By Cancer Diagnostics & Treatment
- 1.5.3.3.2 GCC Oncology Market, By Cancer Type
- 1.5.3.4 RoW Countries
- 1.5.3.4.1 RoW Countries Oncology Market, By By Cancer Diagnostics & Treatment
- 1.5.3.4.2 RoW Countries Oncology Market, By Cancer Type
- TABLE 1. GLOBAL ONCOLOGY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- TABLE 2. NORTH AMERICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 3. NORTH AMERICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 4. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 5. U.S. ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 6. U.S. ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 7. CANADA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 8. CANADA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 9. MEXICO ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 10. MEXICO ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 11. EUROPE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 12. EUROPE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 13. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 14. GERMANY ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 15. GERMANY ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 16. FRANCE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 17. FRANCE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 18. UK ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 19. UK ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 20. ITALY ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 21. ITALY ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 22. SPAIN ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 23. SPAIN ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 24. REST OF EUROPE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 25. REST OF EUROPE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 26. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 27. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 28. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 29. CHINA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 30. CHINA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 31. INDIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 32. INDIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 33. JAPAN ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 34. JAPAN ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 35. AUSTRALIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 36. AUSTRALIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 37. SOUTH KOREA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 38. SOUTH KOREA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 39. REST OF ASIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 40. REST OF ASIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 41. REST OF WORLD ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 42. REST OF WORLD ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 43. REST OF WORLD ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- TABLE 44. BRAZIL ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 45. BRAZIL ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 46. SOUTH AFRICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 47. SOUTH AFRICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 48. GCC ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- TABLE 49. GCC ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- TABLE 50. ROW COUNTRIES ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 1. GLOBAL ONCOLOGY MARKET VALUE, BY REGION, 2020-2029, MILLION USD
- FIGURE 2. NORTH AMERICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 3. NORTH AMERICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 4. NORTH AMERICA ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 5. U.S. ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 6. U.S. ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 7. CANADA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 8. CANADA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 9. MEXICO ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 10. MEXICO ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 11. EUROPE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 12. EUROPE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 13. EUROPE ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 14. GERMANY ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 15. GERMANY ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 16. FRANCE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 17. FRANCE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 18. UK ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 19. UK ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 20. ITALY ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 21. ITALY ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 22. SPAIN ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 23. SPAIN ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 24. REST OF EUROPE ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 25. REST OF EUROPE ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 26. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 27. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 28. ASIA-PACIFIC ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 29. CHINA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 30. CHINA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 31. INDIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 32. INDIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 33. JAPAN ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 34. JAPAN ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 35. AUSTRALIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 36. AUSTRALIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 37. SOUTH KOREA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 38. SOUTH KOREA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 39. REST OF ASIA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 40. REST OF ASIA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 41. REST OF WORLD ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 42. REST OF WORLD ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 43. REST OF WORLD ONCOLOGY MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
- FIGURE 44. BRAZIL ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 45. BRAZIL ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 46. SOUTH AFRICA ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 47. SOUTH AFRICA ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 48. GCC ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
- FIGURE 49. GCC ONCOLOGY MARKET VALUE, BY CANCER TYPE, 2020-2029, MILLION USD
- FIGURE 50. ROW COUNTRIES ONCOLOGY MARKET VALUE, BY BY CANCER DIAGNOSTICS & TREATMENT, 2020-2029, MILLION USD
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.